HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

silibor

hepatoprotective flavonoid preparation from thistle Silybum marianum

Networked: 5 relevant articles (2 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrans: 130
    - Benzopyrans: 195
      - Chromones: 159
        Flavonoids: 9773
        silibor: 5
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzopyrans: 195
      - Chromones: 159
        Flavonoids: 9773
        silibor: 5

Experts

1.	Fira, Liudmyla: 1 article (10/2021)
2.	Herasymets, Iryna: 1 article (10/2021)
3.	Medvid, Ihor: 1 article (10/2021)

Related Diseases

1.	Hepatitis 07/01/1992 - "Benzonal was found to be more effective in correcting the impaired monooxygenase enzyme system of hepatic cells in immature rats with acute hepatitis than silibor, phytin and zyxorin."
2.	Type 2 Diabetes Mellitus (MODY) 09/01/1993 - "A ten-day course of karsil (silimarin, legalon) or silibor therapy improved the absorption (as indicated by ueviridin test) and oxidative-antitoxic (as shown by antipyrine test) hepatocyte functions in patients with non-insulin-dependent diabetes mellitus with hepatosis. "
3.	Dyskinesias (Dyskinesia) 01/01/1990 - "A study is presented of the lipid and mineral metabolism composition in 60 patients with diseases of the biliary tract (dyskinesias, chronic noncalculous cholecystitis, cholelithiasis) before and after treatment with a hepatoprotective agent silibor, with a dry protein mixture containing amino acids and minerals and a vitamin-mineral agent quadevit. "
4.	Cholelithiasis 01/01/1990 - "A study is presented of the lipid and mineral metabolism composition in 60 patients with diseases of the biliary tract (dyskinesias, chronic noncalculous cholecystitis, cholelithiasis) before and after treatment with a hepatoprotective agent silibor, with a dry protein mixture containing amino acids and minerals and a vitamin-mineral agent quadevit. "
5.	Cholecystitis 01/01/1990 - "A study is presented of the lipid and mineral metabolism composition in 60 patients with diseases of the biliary tract (dyskinesias, chronic noncalculous cholecystitis, cholelithiasis) before and after treatment with a hepatoprotective agent silibor, with a dry protein mixture containing amino acids and minerals and a vitamin-mineral agent quadevit. "

Related Drugs and Biologics

1.	Silymarin
2.	Phytic Acid (Inositol Hexaphosphate)
3.	Mixed Function Oxygenases (Monooxygenases)
4.	Enzymes
5.	Antipyrine (Phenazone)
6.	flumecinol
7.	benzobarbital
8.	Vitamins
9.	Proteins (Proteins, Gene)
10.	Minerals

Related Therapies and Procedures

1.	Therapeutics
2.	Aftercare (After-Treatment)